Cotransmitter-mediated locus coeruleus action on motoneurons

doi:10.1016/0361-9230(94)90155-4

Brain Research Bulletin

Volume 35, Issues 5–6, 1994, Pages 423-432

https://doi.org/10.1016/0361-9230(94)90155-4 Get rights and content

Abstract

This article reviews evidence for a direct noradrenergic projection from the dorsolateral pontine tegmentum (DLPT) to spinal motoneurons. The existence of this direct pathway was first inferred by the observation that antidromically evoked responses occur in single cells in the locus coeruleus (LC), a region within the DLPT, following electrical stimulation of the ventral horn of the lumbar spinal cord of the cat. We subsequently confirmed that there is a direct noradrenergic pathway from the LC and adjacent regions of the DLPT to the lumbar ventral horn using anatomical studies that combined retrograde tracing with immunohistochemical identification of neurotransmitters. These anatomical studies further revealed that many of the noradrenergic neurons in the LC and adjacent regions of the DLPT of the cat that send projections to the spinal cord ventral horn also contain colocalized glutamate (Glu) or enkephalin (ENK). Recent studies from our laboratory suggest that Glu and ENK may function as cotransmitters with norepinephrine (NE) in the descending pathway from the DLPT. Electrical stimulation of the LC evokes a depolarizing response in spinal motoneurons that is only partially blocked by α₁ adrenergic antagonists. In addition, NE mimicks only the slowly developing and not the fast component of LC-evoked depolarization. Furthermore, the depolarization evoked by LC stimulation is accompanied by a decrease in membrane resistance, whereas that evoked by NE is accompanied by an increased resistance. That Glu may be a second neurotransmitter involved in LC excitation of motoneurons is supported by our observation that the excitatory response evoked in spinal cord ventral roots by electrical stimulation of the LC is attenuated by a $non -N- methyl- d -aspartate$ glutamatergic antagonist. ENK may participate as a cotransmitter with NE to mediate LC effects on lumbar monosynaptic reflex (MSR) amplitude. Electrical stimulation of the LC has a biphasic effect on MSR amplitude, facilitation followed by inhibition. Adrenergic antagonists block only the facilitatory effect of LC stimulation on MSR amplitude, whereas the ENK antagonist naloxone reverses the inhibition. The chemical heterogeneity of the cat DLPT system and the differential responses of motoneurons to the individual cotransmitters help to explain the diversity of postsynaptic potentials that occur following LC stimuli.

References (89)

H. Allaoua et al.
Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients
Brain Res.
(1992)
E. Bastiaensen et al.
Subcellular fractionation of bovine ganglion stellatum: Co-storage of noradrenaline, Met-enkephalin and neuropeptide Y in large ‘dense-cored’ vesicles
Brain Res.
(1988)
J.T. Buchanan et al.
Transplants of embryonic brainstem containing the locus coeruleus into spinal cord enhance the hindlimb flexion reflex in adult rats
Brain Res.
(1986)
J.Y.H. Chan et al.
Facilitation of lumbar monosynaptic reflexes by locus coeruleus in the rat
Brain Res.
(1986)
F.M. Clark et al.
Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons
Brain Res.
(1992)
J.W. Commissiong et al.
A new projection from locus coeruleus to the spinal ventral columns: Histochemical and biochemical evidence
Brain Res.
(1978)
G.E. Fagg et al.
Descending fibre-mediated release of endogenous glutamate and glycine from the perfused cat spinal cord in vivo
Brain Res.
(1978)
S.M. Fleetwood-Walker et al.
Contribution of noradrenaline-, dopamine- and adrenaline-containing axons to the innervation of different regions of the spinal cord of the cat
Brain Res.
(1981)
M. Fodor et al.
Immunohistochemical study on the distribution of neuropeptides within the pontine tegmentum—particularly the parabrachial nuclei and the locus coeruleus of the human brain
Neuroscience
(1992)
S.J. Fung et al.
Evidence of facilitatory coerulospinal action in lumbar motoneurons of cats
Brain Res.
(1981)

S.J. Fung et al.

Locus coeruleus control of spinal cord activity. Brainstem control of spinal cord function

S.J. Fung et al.

Membrane excitability changes in hind-limb motoneurons induced by stimulation of the locus coeruleus in cats

Brain Res.

(1987)

S.J. Fung et al.

Locus coeruleus control of spinal motor output

Prog. Brain Res.

(1991)

S.J. Fung et al.

Coerulospinal cells containing neuropeptide Y in the cat

Peptides

(1991)

T. Furuyama et al.

Region-specific expression of subunits of iontropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with specific reference to nociception

Mol. Brain Res.

(1993)

H.S. Goldsmith et al.

Axonal regeneration after spinal cord transection and reconstruction

Brain Res.

(1992)

C. Gouarderes et al.

High resolution radioautographic localization of [¹²⁵I]FK-33–824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats

Neuroscience

(1991)

P.G. Guyenet

The coeruleospinal noradrenergic neurons: Anatomical and electrophysiological studies in the rat

Brain Res.

(1980)

M.B. Hancock et al.

Spinal projections from the nucleus locus coeruleus and nucleus subcoeruleus in the cat and monkey as demonstrated by the retrograde transport of horseradish peroxidase

Brain Res. Bull.

(1976)

G. Holstege et al.

Anatomical evidence for direct brain stem projection to the somatic motoneuronal cell groups and autonomic preganglionic cell groups in cat spinal cord

Brain Res.

(1979)

J.R. Howe et al.

Characterization of [³H]rauwolscine binding to alpha₂-adrenoceptor sites in the lumbar spinal cord of the cat: Comparison to such binding sites in the cat frontal cerebral cortex

Brain Res.

(1986)

T. Kaneko et al.

Immunohisto-chemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain

Brain Res.

(1990)

H.G.J.M. Kuypers et al.

Funicular trajectories of descending brain stem pathways in cat

Brain Res.

(1977)

Y.-Y. Lai et al.

A spinal projection of serotonergic neurons of the locus coeruleus in the cat

Neurosci. Lett.

(1985)

Y.-Y. Lai et al.

The actions of two monoamines on spinal motoneurons from stimulation of the locus coeruleus in the cat

Brain Res.

(1989)

J. Lechner et al.

Brainstem peptidergic neurons projecting to the medial and lateral thalamus and zona incerta in the rat

Brain Res.

(1993)

L. Leger et al.

Localization of substance P- and enkephalin-like immunoreactivity in relation to catecholamine-containing cell bodies in the cat dorsolateral pontine tegmentum: An immunofluorescence study

Neuroscience

(1983)

J.L. Maderdrut et al.

Distribution and development of proenkephalin-like immunoreactivity in the lumbar spinal cord of the chicken

Brain Res.

(1986)

S.A. Marks et al.

[³H]Prazosin binding in the intermediolateral cell column and the effects of iontophoresed methoxamine on sympathetic preganglionic neuronal activity in the anaesthetized cat and rat

Brain Res.

(1990)

M.L. Mayer et al.

The physiology of excitatory amino acids in the vertebrate central nervous system

Prog. Neurobiol.

(1987)

L.F. McNicholas et al.

Innervation of the spinal cord by sympathetic fibers

Exp. Neurol.

(1980)

S. Miachon et al.

Identification of catecholamine cell bodies in the pons and ponsmesencephalon junction of the cat brain, using tyrosine hydroxylase and dopamine-β-hydroxylase immunohistochemistry

Brain Res.

(1984)

J.J. Mitchell et al.

Quantitative autoradiographic analysis of excitatory amino acid receptors in the cat spinal cord

Neurosci. Lett.

(1991)

P.J. Monroe et al.

Evaluation of the interactions of serotonergic and adrenergic drugs with μ, δ, and κ opioid binding sites

Neurosci. Lett.

(1991)

P. Mouchet et al.

Immunohistochemical study of catecholaminergic cell bodies in the rat spinal cord

Brain Res. Bull.

(1986)

P. Mouchet et al.

Immunohistochemical study of the catecholaminergic innervation of the spinal cord of the rat using specific antibodies against dopamine and noradrenaline

J. Chem. Neuroanat.

(1992)

T. Nakazato

Locus coeruleus neurons projecting to the forebrain and the spinal cord in the cat

Neuroscience

(1987)

A.P. Nicholas et al.

Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate

Neuroscience

(1992)

L.G. Nygren et al.

A new major projection from locus coeruleus: The main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord

Brain Res.

(1977)

O. Pompeiano et al.

Responses of locus coeruleus and subcoeruleus neurons to sinusoidal stimulation of labyrinth receptors

Neuroscience

(1990)

V.K. Reddy et al.

Pontospinal transmitters and their distribution

Prog. Brain Res.

(1991)

B. Scatton et al.

Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbarspinal cord of parkinsonian patients

Brain Res.

(1986)

B. Skoog et al.

Do noradrenergic descending tract fibres contribute to the depression of transmission from group II muscle afferents following brainstem stimulationin the cat?

Neurosci. Lett.

(1991)

K.A. Sluka et al.

Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat

Brain Res.

(1992)

Cited by (42)

A neural circuit for regulating a behavioral switch in response to prolonged uncontrollability in mice
2023, Neuron
Persistence in the face of failure helps to overcome challenges. But the ability to adjust behavior or even give up when the task is uncontrollable has advantages. How the mammalian brain switches behavior when facing uncontrollability remains an open question. We generated two mouse models of behavioral transition from action to no-action during exposure to a prolonged experience with an uncontrollable outcome. The transition was not caused by pain desensitization or muscle fatigue and was not a depression-/learned-helplessness-like behavior. Noradrenergic neurons projecting to GABAergic neurons within the orbitofrontal cortex (OFC) are key regulators of this behavior. Fiber photometry, microdialysis, mini-two-photon microscopy, and tetrode/optrode in vivo recording in freely behaving mice revealed that the reduction of norepinephrine and downregulation of alpha 1 receptor in the OFC reduced the number and activity of GABAergic neurons necessary for driving action behavior resulting in behavioral transition. These findings define a circuit governing behavioral switch in response to prolonged uncontrollability.
Stochastic spinal neuromodulation tunes the intrinsic logic of spinal neural networks
2022, Experimental Neurology
Citation Excerpt :
This ‘bistable’ behavior of distinct motoneurons provides an additional non-linear contribution to changes in cell excitability. Motoneuronal output is also regulated by descending serotoninergic (Fung and Barnes, 1989) and noradrenergic neurons originating in supraspinal structures (Fung et al., 1994). For instance, electrical stimulation in the brainstem of the Raphe nucleus (Kaneko et al., 1984) and the locus coeruleus (Strahlendorf et al., 1980; Chan et al., 1986; Fung et al., 1991) modulates spinal reflexes by putatively exploiting tonically active descending pathways (Engberg et al., 1968; Jones and Gebhart, 1987).
The present review focuses on the physiological states of spinal networks, which are stochastically modulated by continuously changing ensembles of proprioceptive and supraspinal input resulting in highly redundant neural networks. Spinal epidural interfaces provide a platform for probing spinal network dynamics and connectivity among multiple motor pool-specific spinal networks post-injury under in vivo experimental conditions. Continuous epidural low-frequency pulses at low intensity can evoke motor responses of stochastically changing amplitudes and with an oscillatory pattern of modulation. The physiological significance of this oscillatory pattern, intrinsic to “resting” spinal networks and observed in both uninjured and injured locomotor circuits, is unclear. This neural variability among spinal networks appears to be a fundamental mechanism of the network's design and not a “noise” interfering with movement control. Data to date also suggest that the greater the level of stimulation above motor threshold, the greater the loss of modulation over the motor output that is physiologically provided by interneuronal networks, which integrate naturally occurring proprioceptive and cutaneous input generated during movement. Sub-motor threshold spinal electrical stimulation experiments demonstrate a range of functional improvements of multiple physiological systems when used in concert with sensorimotor training after spinal cord injury. Although our understanding of the systemic, cellular and molecular modulatory mechanisms that trigger these activity-dependent adaptive processes remain incomplete, some basic physiological principles have evolved, at least at the systemic and neural network levels and to some degree at the cellular level.
Expression of the noradrenaline transporter in the peripheral nervous system
2020, Journal of Chemical Neuroanatomy
Citation Excerpt :
In the brainstem of the rat, noradrenergic neurons project from the locus coeruleus and subcoeruleus to the dorsal and ventral horns of the spinal cord (Holstege and Bongers, 1991; Proudfit and Clark, 1991). These descending noradrenergic pathways modulate spinal nociceptive transmission and motor responses (Jones, 1991; Fung et al., 1994; Hentall et al., 2003; Harvey et al., 2006; Machacek and Hochman, 2006). In the present study, SP (a marker of primary nociceptive afferent fibres) was concentrated in the superficial laminae of the dorsal horn adjacent to but not co-localised with noradrenergic markers (NAT and DβH).
The noradrenaline transporter (NAT) transfers noradrenaline released into the synaptic cleft back into the presynaptic terminal, thus terminating neurotransmission. Although the distribution of NAT within the central nervous system has been well-characterized, less is known about its distribution elsewhere in the peripheral nervous system and in organs such as the skin. To address this in the present study, NAT expression was investigated using immunohistochemistry in the hind paw skin and more proximally in the sciatic nerve, dorsal root ganglia and spinal cord of five male Wistar rats. It was hypothesised that NAT would be expressed exclusively on nerve fibres labelled by dopamine beta hydroxylase (DβH), an enzyme involved in the conversion of dopamine to noradrenaline. NAT co-localised with DβH in neurons in the spinal cord, dorsal root ganglia and sciatic nerve. Unexpectedly, however, NAT-like immunoreactivity was not observed in DβH immuno-reactive fibres that innervated dermal blood vessels, suggesting that a mechanism other than presynaptic re-uptake of noradrenaline through NAT regulates transmission at neurovascular junctions in the skin. Furthermore, a novel association between NAT-like immunoreactivity and the myelin marker myelin basic protein (MBP) was identified in peripheral nerves. Specifically, NAT and MBP appeared to congregate around primary afferent nerve fibres labelled by neurofilament 200, a marker of neurons with medium- and large-diameter axons. NAT-like immunoreactivity was also detected in cultured Schwann cells immunohistochemically and at the mRNA level. Together, these findings imply a hitherto unrecognised role of Schwann cells in clearance of noradrenaline in the peripheral nervous system.
Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection
2017, Neuroscience
The mechanism of action of botulinum neurotoxin type A (BoNT/A) is well characterized, but some published evidence suggests the potential for neuronal retrograde transport and cell-to-cell transfer (transcytosis) under certain experimental conditions. The present study evaluated the potential for these processes using a highly selective antibody for the BoNT/A-cleaved substrate (SNAP25₁₉₇) combined with 3-dimensional imaging. SNAP25₁₉₇ was characterized in a rat motor neuron (MN) pathway following toxin intramuscular injections at various doses to determine whether SNAP25₁₉₇ is confined to MNs or also found in neighboring cells or nerve fibers within spinal cord (SC). Results demonstrated that SNAP25₁₉₇ immuno-reactive staining was colocalized with biomarkers for MNs, but not with markers for neighboring neurons, nerve fibers or glial cells. Additionally, a high dose of BoNT/A, but not a lower dose, resulted in sporadic SNAP25₁₉₇ signal in distal muscles and associated SC regions without evidence for transcytosis, suggesting that the staining was due to systemic spread of the toxin. Despite this spread, functional effects were not detected in the distal muscles. Therefore, under the present experimental conditions, our results suggest that BoNT/A is confined to MNs and any evidence of distal activity is due to limited systemic spread of the toxin at higher doses and not through transcytosis within SC. Lastly, at higher doses of BoNT/A, SNAP25₁₉₇ was expressed throughout MNs and colocalized with synaptic markers on the plasma membrane at 6 days post-treatment. These data support previous studies suggesting that SNAP25₁₉₇ may be incorporated into SNARE-protein complexes within the affected MNs.
Effect of antispastic drugs on motor reflexes and voluntary muscle contraction in incomplete spinal cord injury
2014, Archives of Physical Medicine and Rehabilitation
Citation Excerpt :
In the current study, tizanidine had a stronger inhibitory effect on knee extensors and plantar flexors whereas baclofen had a stronger inhibitory effect on knee flexors. We postulate that the preferential effects on particular muscle groups are due to actions of tizanidine on noradrenergic alpha2 receptors, which are driven largely by reticulospinal pathways, originating from the locus coeruleus.30-33 Noradrenergic alpha1 receptors may have an excitatory effect on motor pools, whereas the alpha2 receptors have an inhibitory effect on extensor muscles.34-36
To investigate the effects of antispastic drugs baclofen and tizanidine on reflexes and volitional tasks.
Double-blind, placebo-controlled, crossover, before-after trial, pilot study.
Research laboratory in a rehabilitation hospital.
Men with chronic (>6mo) motor incomplete spinal cord injury (N=10) were recruited for the study.
Tizanidine, baclofen, and placebo were tested in this study. Agents were tested in separate experimental sessions separated by >1 week.
Reflex and strength were measured before and after the administration of a single dose of each intervention agent. Electromyographic and joint torque data were collected during assessments of plantar flexor stretch reflexes, maximum contraction during motor-assisted isokinetic movements, and maximum isometric knee extension and flexion.
Reduced stretch reflex activity was observed after the administration of either tizanidine or baclofen. We observed that tizanidine had a stronger inhibitory effect on knee extensors and plantar flexors whereas baclofen had a stronger inhibitory effect on the knee flexors. The effects of these drugs on strength during isometric and isokinetic tasks varied across participants, without a consistent reduction in torque output despite decreased electromyographic activity.
These results suggest that antispastic drugs are effective in reducing stretch reflexes without substantially reducing volitional torque. Differential effects of tizanidine and baclofen on reflexes of flexors and extensors warrant further investigation into patient-specific management of antispastic drugs.
Projections from the rat cuneiform nucleus to the A7, A6 (locus coeruleus), and A5 pontine noradrenergic cell groups
2013, Journal of Chemical Neuroanatomy
Stimulation of neurons in the cuneiform nucleus (CnF) produces antinociception and cardiovascular responses that could be mediated, in part, by noradrenergic neurons that innervate the spinal cord dorsal horn. The present study determined the projections of neurons in the CnF to the pontine noradrenergic neurons in the A5, A6 (locus coeruleus), and A7 cell groups that are known to project to the spinal cord. Injections of the anterograde tracer, biotinylated dextran amine in the CnF of Sasco Sprague-Dawley rats labeled axons located near noradrenergic neurons that were visualized by processing tissue sections for tyrosine hydroxylase-immunoreactivity. Anterogradely labeled axons were more dense on the side ipsilateral to the BDA deposit. Both A7 and A5 cell groups received dense projections from neurons in the CnF, whereas locus coeruleus received only a sparse projection. Highly varicose anterogradely labeled axons from the CnF were found in close apposition to dendrites and somata of tyrosine hydroxylase-immunoreactive neurons in pontine tegmentum. Although definitive evidence for direct pathways from CnF neurons to the pontine noradrenergic cell groups requires ultrastructural analysis, the results of the present studies provide presumptive evidence of direct projections from neurons in the CnF to the pontine noradrenergic neurons of the A7, locus coeruleus, and A5 cell groups. These results support the suggestion that the analgesia and cardiovascular responses produced by stimulation of neurons in the CnF may be mediated, in part, by pontine noradrenergic neurons.

View all citing articles on Scopus

²: Present address: Veterans General Hosp., VACRS, Taipei, Taiwan 112, Republic of China.

³: Present address: Dept. Fisiol. e Biochim., Univ. di Pisa, Via S Zeno 31, 56100 Pisa, Italy.

⁴: Present address: Dept. Psychiat., Neurobiol. Res., 151A3, VA Med. Ctr., Sepulveda, CA 91343.

⁵: Present address: Dept. Neurosci., Texas Tech. Univ. Hlth. Sci. Ctr., Lubbock, TX 79430.

⁶: Present address: Dept. Pharmacol., Uniformed Services Univ. Hlth. Sci., Bethesda, MD 20814.

⁷: Present address: Dept. Physiol., UCLA, Los Angeles, CA 90024.

View full text

ArticleCotransmitter-mediated locus coeruleus action on motoneurons

Abstract

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Neuroscience

Brain Res.

Brain Res.

Prog. Brain Res.

Peptides

Mol. Brain Res.

Brain Res.

Neuroscience

Brain Res.

Brain Res. Bull.

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Neurosci. Lett.

Brain Res.

Brain Res.

Neuroscience

Brain Res.

Brain Res.

Prog. Neurobiol.

Exp. Neurol.

Brain Res.

Neurosci. Lett.

Neurosci. Lett.

Brain Res. Bull.

J. Chem. Neuroanat.

Neuroscience

Neuroscience

Brain Res.

Neuroscience

Prog. Brain Res.

Brain Res.

Neurosci. Lett.

Brain Res.

Article
Cotransmitter-mediated locus coeruleus action on motoneurons